中科微点-全球专利检索

  1. Login
  2. Sign Up

Search Results

12 records (took 0.013 seconds)

    Rubber material with barrier material made of cycloolefin copolymers
    1.
    发明授权
    Rubber material with barrier material made of cycloolefin copolymers 有权
    具有由环烯烃共聚物制成的阻隔材料的橡胶材料

    公开(公告)号：US09382395B2

    公开(公告)日：2016-07-05

    申请号：US14421532

    申请日：2013-08-02

    Applicant: BASF SE

    Inventor： Theo Smit ,  Kevin Mueller ,  Stefan Dahmen ,  Norma Lidia Negrete Herrera ,  Bernhard Sturm

    IPC: C08F10/00 ,  C08C19/04 ,  C08G61/08 ,  C08F2/46 ,  B32B27/32 ,  B05D3/02 ,  C08J7/18 ,  B60C5/02 ,  C08J7/04 ,  C09D165/00 ,  B60C1/00 ,  C08F232/08 ,  C09D145/00

    CPC classification number: C08J7/047 ,  B60C1/0008 ,  C08F232/08 ,  C08G61/08 ,  C08G2261/3322 ,  C08G2261/3324 ,  C08G2261/418 ,  C08G2261/612 ,  C08J2307/00 ,  C08J2445/00 ,  C09D145/00 ,  C09D165/00 ,  Y10T428/31833

    Abstract: The use of a certain copolymer is described for reducing the gas-permeability of rubber material. A rubber material provided with a barrier material in the form of the copolymer is also described. The copolymer can be produced via ring-opening metathesis polymerization of a) one first olefin monomer selected from the group consisting of cyclic olefin monomers having at least one endocyclic C—C double bond, where no tertiary carbon atom bearing a hydrogen atom is present in alpha-position to the double bond, and b) one second olefin monomer selected from the group consisting of cyclic olefin monomers having one endocyclic C—C double bond, where a tertiary carbon atom bearing a hydrogen atom is present in at least one alpha-position to the double bond, where the copolymer has been oxidized at least to some extent, where the amount of polycyclic olefin monomers used to produce the copolymer with at least two C—C double bonds is zero or less than 1 mol %, based on the entirety of the monomers.

    Abstract translation: 描述了某种共聚物的用途，用于降低橡胶材料的气体渗透性。 还描述了设置有共聚物形式的阻挡材料的橡胶材料。 共聚物可以通过a）一种选自由具有至少一个具有氢原子的叔碳原子存在的至少一个环内C-C双键的环烯烃单体组成的组中的一种第一烯烃单体的开环易位聚合制备 和b）选自具有一个环内C-C双键的环烯烃单体的一个第二烯烃单体，其中带有氢原子的叔碳原子存在于至少一个α-烯烃单体中， 至少在一定程度上氧化共聚物的位置，其中用于制备具有至少两个C-C双键的共聚物的多环烯烃单体的量为零或小于1摩尔％，基于 整个单体。

    PROCESS FOR PRODUCING COMPOSITE MATERIALS
    3.
    发明申请
    PROCESS FOR PRODUCING COMPOSITE MATERIALS 审中-公开
    生产复合材料的方法

    公开(公告)号：US20140017411A1

    公开(公告)日：2014-01-16

    申请号：US13940835

    申请日：2013-07-12

    Applicant: BASF SE

    Inventor： Arno Lange ,  Theo Smit ,  Rainer Dyllick-Brenzinger ,  Gerhard Cox ,  Oliver Gronwald ,  Judith Christine Bräuer ,  Stefan Spange ,  Tina Löschner ,  Patrick Kempe

    IPC: C09D183/04

    CPC classification number: C09D183/04 ,  C08G77/50

    Abstract: The present invention relates to a process for producing composite materials formed from a) at least one inorganic or organometallic phase; and b) at least one organic polymer phase with aromatic or heteroaromatic structural units; comprising the homo- or copolymerization of at least one monomer of the formula I in which M is a metal or semimetal; R1, R2 may be the same or different and are each an Ar—C(Ra,Rb)— radical in which Ar is as defined in claim 1, or the R1Q and R2G radicals together are a radical of the formula A in which A is an aromatic or heteroaromatic ring fused to the double bond, m is 0, 1 or 2, and the R radicals may be the same or different and are as defined in claim 1; G, Q are each O, S or NH; Q is O, S or NH; and in which q, X, Y, R1′, R2′ are each as defined in claim 1; which comprises performing the polymerization of the monomers of the general formula I thermally in the absence or substantial absence of added catalysts.

    Abstract translation: 本发明涉及由a）至少一种无机或有机金属相形成的复合材料的制造方法。 和b）至少一个具有芳族或杂芳族结构单元的有机聚合物相; 包括其中M是金属或半金属的至少一种式I的单体的均聚或共聚合; R 1，R 2可以相同或不同，并且各自为Ar-C（Ra，Rb） - 基团，其中Ar如权利要求1所定义，或者R1Q和R2G基团一起是式A的基团，其中A 是与双键稠合的芳族或杂芳族环，m是0,1或2，R基可以相同或不同，如权利要求1所定义; G，Q各自为O，S或NH; Q是O，S或NH; 并且其中q，X，Y，R 1'，R 2'各自如权利要求1所定义; 其包括在不存在或基本不存在添加的催化剂的情况下热分解通式I的单体。

    NOVEL COPOLYMERS AND THEIR USE IN PHARMACEUTICAL DOSAGE FORMS
    9.
    发明公开
    NOVEL COPOLYMERS AND THEIR USE IN PHARMACEUTICAL DOSAGE FORMS 审中-公开

    公开(公告)号：US20230257501A1

    公开(公告)日：2023-08-17

    申请号：US18014508

    申请日：2021-07-02

    Applicant: BASF SE

    Inventor： Theo Smit ,  Ferdinand Paul Brandl ,  Felicitas Guth ,  Karl Kolter ,  Frank Schmidt

    IPC: C08F226/10 ,  C08F2/06 ,  A61K9/16

    CPC classification number: C08F226/10 ,  C08F2/06 ,  A61K9/1635

    Abstract: Copolymer, wherein structural units are derived from: i) an acrylic carboxylic acid monomer (4 to 18% by weight), selected from the group consisting of acrylic acid and methacrylic acid, ii) a 5 hydrophobic methacrylate (more than 8% by weight), selected from a group consisting of isopropyl methacrylate, tert-butyl methacrylate and cyclohexyl methacrylate, iii) a N-vinyl lactam, selected from a group consisting of N-vinyl pyrrolidone and N-vinylcaprolactam and optionally iv) 2-hydroxyethyl methacrylate, with the proviso that the total amount of structural units derived from the monomer groups adds up to 100% by weight, and the calculated solubility parameter SP of 10 the copolymer is between 22.0 and 25.0 MPa1/2, and the use of the copolymers as crystallization inhibitors in pharmaceutical dosage forms for inhibiting the recrystallization of an active ingredient in an aqueous environment of a human or animal body.

    NOVEL TERPOLYMERS AND THEIR USE IN PHARMACEUTICAL DOSAGE FORMS
    10.
    发明申请
    NOVEL TERPOLYMERS AND THEIR USE IN PHARMACEUTICAL DOSAGE FORMS 有权

    公开(公告)号：US20210069112A1

    公开(公告)日：2021-03-11

    申请号：US16772273

    申请日：2018-12-07

    Applicant: BASF SE

    Inventor： Ferdinand Paul Brandl ,  Theo Smit ,  Felicitas Guth ,  Karl Kolter ,  Maximilian Angel ,  Frank Schmidt

    IPC: A61K9/16 ,  C08F220/18 ,  A61K47/32 ,  A61K31/635 ,  A61K31/58 ,  A61K31/216 ,  A61K31/5377

    Abstract: Terpolymer, wherein 20 to 35% by weight of the structural units are derived from acrylic acid, 45 to 60% by weight of the structural units from a hydrophobic methacrylate selected from a group consisting of isopropyl methacrylate, tert-butyl methacrylate and cyclohexyl methacrylate and 15 to 40% by weight of the structural units from a third olefinic monomer selected from the group consisting of N-vinyl lactam, hydroxy ethyl methacrylate and phenoxyethyl acrylate with the proviso that the total amount of structural units derived from the three monomer groups adds up to 100% by weight, and the use of the terpolymers as crystallization inhibitors in pharmaceutical dosage forms for inhibiting the recrystallization in an aqueous environment of a human or animal body of an active ingredient.

Patent Agency Ranking